BR9911773A - Compostos de moraxella catarrhalis - Google Patents

Compostos de moraxella catarrhalis

Info

Publication number
BR9911773A
BR9911773A BR9911773-8A BR9911773A BR9911773A BR 9911773 A BR9911773 A BR 9911773A BR 9911773 A BR9911773 A BR 9911773A BR 9911773 A BR9911773 A BR 9911773A
Authority
BR
Brazil
Prior art keywords
compounds
moraxella catarrhalis
polypeptides
basbo20
prophylactic
Prior art date
Application number
BR9911773-8A
Other languages
English (en)
Inventor
Joelle Thonnard
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of BR9911773A publication Critical patent/BR9911773A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Patente de Invenção: "COMPOSTOS DE MORAXELLA CATARRHALIS". A invenção fornece polipeptídios BASBO20 e polinucleotídeos codificando polipeptídios BASBO20 e métodos para a produção desses polipeptídios por técnicas recombinantes. Também são fornecidos usos diagnósticos, profiláticos e terapêuticos.
BR9911773-8A 1998-05-13 1999-05-07 Compostos de moraxella catarrhalis BR9911773A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810285.8A GB9810285D0 (en) 1998-05-13 1998-05-13 Novel compounds
PCT/EP1999/003257 WO1999058684A2 (en) 1998-05-13 1999-05-07 Compounds from moraxella catarrhalis

Publications (1)

Publication Number Publication Date
BR9911773A true BR9911773A (pt) 2002-03-05

Family

ID=10831997

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911773-8A BR9911773A (pt) 1998-05-13 1999-05-07 Compostos de moraxella catarrhalis

Country Status (23)

Country Link
US (2) US7122197B1 (pt)
EP (1) EP1078064B1 (pt)
JP (1) JP4503175B2 (pt)
KR (1) KR100610448B1 (pt)
CN (3) CN1210401C (pt)
AT (1) ATE303442T1 (pt)
AU (1) AU737196B2 (pt)
BR (1) BR9911773A (pt)
CA (1) CA2328502A1 (pt)
CZ (1) CZ298227B6 (pt)
DE (1) DE69927017T2 (pt)
DK (1) DK1078064T3 (pt)
ES (1) ES2247803T3 (pt)
GB (1) GB9810285D0 (pt)
HK (1) HK1036299A1 (pt)
HU (1) HUP0102853A3 (pt)
IL (2) IL139612A0 (pt)
NO (1) NO330169B1 (pt)
NZ (1) NZ508322A (pt)
PL (1) PL199497B1 (pt)
TR (1) TR200003345T2 (pt)
WO (1) WO1999058684A2 (pt)
ZA (1) ZA200006522B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
US20060240045A1 (en) 2002-08-02 2006-10-26 Francois-Xavier Berthet Neisserial vaccine compositions comprising a combination of antigens
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
CN111003884B (zh) * 2019-12-05 2021-12-31 浙江海洋大学 重金属污水处理设备及处理方法
CN114703214A (zh) * 2022-03-03 2022-07-05 南京吉芮康生物科技研究院有限公司 一种抗丢失时空可控表达的新型质粒及其应用
WO2024017827A1 (en) 2022-07-19 2024-01-25 Glaxosmithkline Biologicals Sa Continuous process for vaccine production

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552146A (en) 1991-08-15 1996-09-03 Board Of Regents, The University Of Texas System Methods and compositions relating to useful antigens of Moraxella catarrhalis
US5712118A (en) 1993-09-29 1998-01-27 Research Foundation Of State University Of New York Vaccine for branhamella catarrhalis
US6440425B1 (en) * 1995-05-01 2002-08-27 Aventis Pasteur Limited High molecular weight major outer membrane protein of moraxella
US6607731B1 (en) * 1995-09-22 2003-08-19 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6090576A (en) * 1996-03-08 2000-07-18 Connaught Laboratories Limited DNA encoding a transferrin receptor of Moraxella
US7341727B1 (en) * 1996-05-03 2008-03-11 Emergent Product Development Gaithersburg Inc. M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same
WO1998006851A2 (en) * 1996-08-12 1998-02-19 Board Of Regents, The University Of Texas System DEFINING EPITOPES OF THE OUTER MEMBRANE PROTEIN CopB OF $i(MORAXELLA CATARRHALIS)
US6673910B1 (en) 1999-04-08 2004-01-06 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics
AU1824101A (en) 1999-06-18 2001-01-09 Elitra Pharmaceuticals, Inc. Nucleotide sequences of moraxella catarrhalis genome

Also Published As

Publication number Publication date
CZ20004203A3 (en) 2001-05-16
NZ508322A (en) 2002-12-20
NO330169B1 (no) 2011-02-28
PL344792A1 (en) 2001-11-19
DE69927017D1 (de) 2005-10-06
NO20005697D0 (no) 2000-11-10
KR20010043573A (ko) 2001-05-25
JP2002514425A (ja) 2002-05-21
CN100484956C (zh) 2009-05-06
PL199497B1 (pl) 2008-09-30
IL139612A0 (en) 2002-02-10
CN1727359A (zh) 2006-02-01
HUP0102853A1 (hu) 2001-11-28
CN1210401C (zh) 2005-07-13
DK1078064T3 (da) 2006-01-02
AU4142199A (en) 1999-11-29
EP1078064B1 (en) 2005-08-31
JP4503175B2 (ja) 2010-07-14
KR100610448B1 (ko) 2006-08-09
TR200003345T2 (tr) 2001-03-21
EP1078064A2 (en) 2001-02-28
CA2328502A1 (en) 1999-11-18
WO1999058684A2 (en) 1999-11-18
CZ298227B6 (cs) 2007-07-25
ES2247803T3 (es) 2006-03-01
DE69927017T2 (de) 2006-03-16
GB9810285D0 (en) 1998-07-15
ZA200006522B (en) 2001-11-29
US7122197B1 (en) 2006-10-17
CN1309706A (zh) 2001-08-22
IL139612A (en) 2007-07-24
NO20005697L (no) 2001-01-10
CN1876679A (zh) 2006-12-13
ATE303442T1 (de) 2005-09-15
HUP0102853A3 (en) 2008-04-28
US20060147462A1 (en) 2006-07-06
WO1999058684A3 (en) 2000-02-24
HK1036299A1 (en) 2001-12-28
AU737196B2 (en) 2001-08-09

Similar Documents

Publication Publication Date Title
BR9910396A (pt) Polinucleotìdeo(s) e polipeptìdeos basb029 a partirde neisseria meningitidis
BR9911601A (pt) Polipeptìdios antigênicos de neisseria meningitidis, polinucleotìdeos correspondentes e anticorpos protetores
BR9911773A (pt) Compostos de moraxella catarrhalis
GB9820003D0 (en) Novel compounds
BR9914492A (pt) Polipeptìdos basb034 de moraxella catarrhalis e usos dos mesmos
DE69921649D1 (de) Moraxella catarrhalis pilq proteine
GB9809683D0 (en) Novel compounds
ATE312922T1 (de) Moraxella catarrhalis polynukleotide und polypeptide
BR9911609A (pt) Proteìnas e genes de moraxella catarrhalis, antìgenos, anticorpos e usos
GB0025171D0 (en) Novel compounds
WO2000071724A3 (en) Novel compounds from moraxella catarrhalis
DE60043658D1 (de) Basb118 polypeptid und polynukleotid aus moraxella catarrhalis
WO1999058682A3 (en) Compounds from moraxella catarrhalis
HK1047954A1 (zh) 衍生自黏膜炎莫拉氏菌的免疫源性多肽及其用途
ATE274582T1 (de) Basb028 polypeptiden und dafür kodierende polynukleotiden aus moraxella catarrhalis
DE60019614D1 (de) Moraxella catarrhalis antigen basb117
ATE360073T1 (de) Basb119 polypeptid und polynukleotid aus moraxella catarrhalis
WO2001009331A3 (en) Moraxella catarrhalis antigen basb125
DE60019613D1 (de) Moraxella catarrhalis antigen basb120
DE60024456D1 (en) Basb111 polypeptid und polynukleotid aus moraxella catharralis
WO2001009330A3 (en) Moraxella catarrhalis antigen basb121
WO2001009337A3 (en) Moraxella catarrhalis antigens basb122 and basb124
DE60035788D1 (de) Polypeptide aus moraxella (branhamella) catarrhalis

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements